Skip to content
Searchpedia SEO field notes Callum Bennett Callum

Niche files

Pharma SEO

I have seen more pharma sites fail from compliance gaps than from poor backlinks, so start with what you can publish, not what you can build.

Beginner3 min readUpdated 2026-07-27Notes by Callum Bennett

Start here

  • Audit every page for author credentials and a visible review date before you optimise a single meta tag.
  • Build a separate content strategy for patient-facing pages and HCP pages because the search intent and compliance rules differ.
  • Use primary sources such as FDA labels or peer-reviewed studies as citations, not secondary blog posts.
  • Pre-gate, indexable content is your only chance at organic visibility; gated material stays hidden from Google.

Plain-English take

Pharma SEO is the practice of getting pharmaceutical websites to rank in search results while staying inside tight regulatory lines. It is not a separate discipline from standard SEO — it is standard SEO with extra gates. You still need technical foundations, content that matches search intent, and a link profile that signals trust. But you also need to satisfy YMYL (Your Money or Your Life) expectations that Google applies to health content, and you must comply with real-world regulations like FDA or EMA rules on what you can claim about a medicine.

I work with both public-facing pages and healthcare-professional (HCP) portals. The public pages are the ones that can appear in search results. Gated HCP content, even if brilliant, rarely gets indexed. So I focus on the pre-gate pages: the disease overview, the treatment option summary, the patient support programme landing page. Those are the ones that generate organic traffic. For each page, I check that the author is a real person with relevant credentials, that a qualified medical reviewer has signed off, and that the page carries a clear date of last review. Google's Quality Rater Guidelines explicitly reward this.

Keyword research in pharma is narrower than in other verticals. You cannot target a term like "best antidepressant" the same way you would target "best running shoes" because the regulatory and medical implications are different. The [healthcare SEO](/healthcare-seo/) I do for pharma always starts with a compliance check: can this page say that? If not, I pivot to a safer angle or a broader informational query that still answers the user's need without crossing the line.

Authority building in pharma often means earning links from medical journals, official health organisations, and academic institutions. That is slow. I have found that a well-cited, regularly updated page on a disease mechanism can attract more natural links than a dozen outreach campaigns aimed at blogs. The [SaaS SEO](/saas-seo/) playbook of aggressive guest posting does not work here because the domain reputation threshold is higher.

When it actually matters

Pharma SEO matters most when you have a product that patients or HCPs search for actively, but the website is underperforming because of compliance bottlenecks or poor content structure. I have seen sites with strong domain authority rank nowhere for their own drug brand name because the product page was gated behind a login form. That is the first thing I fix: make the brand page indexable with a summary of indications, mechanism, and safety data, while keeping the full prescribing information behind the gate.

It also matters when you launch a new drug or indication. The window before competitors start bidding on the same terms is short. Organic visibility takes months to build, so you need to start the content and technical groundwork before the approval date. One client I worked with had a six-month lead time on a new oncology drug. We used that time to create a patient-facing disease education hub and a separate HCP section with clinical trial data. The [healthcare SEO agency](/healthcare-seo-agency/) tactics I borrowed from included building a dedicated subdomain for each audience segment.

Another scenario where pharma SEO is critical is when you manage a portfolio of legacy products that have generic competition. Patients often search for generic names or class names, not just the branded term. I have to optimise for both without violating rules about comparative claims. For example, I might target "[drug class] for hypertension" rather than comparing my brand directly to a competitor. That requires careful page structure and a clear distinction between the drug's official label and the educational content.

Finally, pharma SEO matters for B2B pharma — the companies that supply ingredients, manufacturing services, or research tools to other pharma companies. That is closer to [B2B SEO](/b2b-seo/) but with added technical documentation and regulatory requirements. The search intent is longer, the decision cycles are longer, and the content needs to satisfy both a scientist and a procurement officer. I have found that detailed whitepapers and case studies, if made indexable with a summary and a clear download gate, can outperform generic service pages.

What I got wrong

I used to think that pharma SEO was mostly about keywords and backlinks, just with stricter compliance. I was wrong. The biggest bottleneck is not link building or keyword research — it is getting the medical and legal teams to approve content fast enough. I once spent three months optimising a page that was perfect by every SEO metric, but it never got published because the medical reviewer flagged a sentence about efficacy that was not supported by the label. Now I involve the regulatory team at the start of the content brief, not after the draft is written.

I also underestimated how much Google penalises missing trust signals. I had a page that ranked well for a rare disease term until Google updated its quality algorithms. The page disappeared. The reason? It had no author name, no credentials, and no date. I assumed the high domain authority of the site would carry it. It did not. Every pharma page now must have at least: author name and credentials, a medical reviewer credit, and a prominent last-updated date. I even add a small note on the page saying "This content was reviewed by Dr. [Name] on [Date]."

Another mistake was treating patient and HCP audiences as the same. I tried to create one page that served both, with a toggle for detail level. It confused both audiences and did not rank for either intent. Now I build separate pages or distinct sections with different keywords, different depth, and different compliance requirements. The patient page uses plain language and avoids off-label mentions. The HCP page uses scientific terminology and includes clinical trial data. The [web design company](/web-design-company/) I worked with helped me set up a clear navigation that separates the two without confusing the user.

Finally, I was too slow to adopt structured data. Pharma pages benefit enormously from MedicalWebPage, HealthTopic, and Drug schema. I now add these to every disease and drug page, even if the SERP does not show rich results yet. The data helps Google understand the content hierarchy, and it future-proofs the page for when the search engine starts displaying health panels. I missed this for a year because I thought schema was only for recipes and reviews.

Next step

Quick answers

How do I handle keyword research for a drug that cannot be advertised directly to consumers?

Focus on disease education terms and treatment class keywords. For example, instead of targeting the brand name, target the condition and the mechanism of action. The page can then mention the drug in context without making promotional claims. Always have the FDA or EMA label as your boundary.

Can I link to external sources like PubMed or clinicaltrials.gov from my pharma page?

Yes, and you should. Citing primary sources like peer-reviewed studies or official trial registries strengthens trust signals. Avoid linking to generic health blogs or unverified patient forums. Google’s YMYL guidelines reward pages that reference authoritative, verifiable sources.

What is the biggest technical SEO issue I should check first on a pharma site?

Indexability of pre-gate content. Many pharma sites block search engines from crawling their product pages because they are behind a login. Use a robots.txt rule or a noindex tag only on the gated parts. Ensure the public summary page is fully indexable, with a clear sitemap and internal links.

Sources

Primary documentation is linked directly. Anything commercial is marked nofollow.

  • Google Search Central — Official guidance on indexing, structured data, and helpful content, which applies directly to pharma SEO.
  • Google Search Quality Rater Guidelines — Explains YMYL and E-E-A-T expectations that determine whether a pharma page ranks or not.
  • FDA — Primary U.S. regulatory source for drug advertising and promotion rules that affect content strategy.
  • European Medicines Agency — EU regulatory standards for medicines, relevant for pharma SEO targeting European markets.
  • NHS — Trusted reference for patient-facing medical content, useful for tone and terminology examples.

Notes from Callum Bennett.